Starna Therapeutics Secures 150 Million Yuan in A-Round Financing

(Source: CPhl.com and Starna Therapeutics)

Starna Therapeutics, a Chinese firm focusing on the research and development of new mRNA drugs, recently announced the completion of round-A financing totaling 150 million yuan ($22.1 million). The lead investor was LYFE Capital, while co-investors were Source Code Capital, Hony Capital and Primavera Venture Par…